Behavioral health company LifeStance Health (NASDAQ: LFST) will be reporting earnings tomorrow before the bell. Here’s what you need to know.
LifeStance Health Group beat analysts’ revenue expectations by 3.6% last quarter, reporting revenues of $325.5 million, up 16% year on year. It was an exceptional quarter for the company, with EBITDA guidance for next quarter exceeding analysts’ expectations and an impressive beat of analysts’ EPS estimates.
Is LifeStance Health Group a buy or sell going into earnings? Read our full analysis here, it’s free.
This quarter, analysts are expecting LifeStance Health Group’s revenue to grow 11% year on year to $333.5 million, slowing from the 18.9% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.01 per share.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. LifeStance Health Group has missed Wall Street’s revenue estimates twice over the last two years.
Looking at LifeStance Health Group’s peers in the healthcare providers & services segment, some have already reported their Q1 results, giving us a hint as to what we can expect. Encompass Health delivered year-on-year revenue growth of 10.6%, beating analysts’ expectations by 1.7%, and Select Medical reported revenues up 2.4%, falling short of estimates by 2.6%. Encompass Health traded up 11.8% following the results while Select Medical was down 21.8%.
Read our full analysis of Encompass Health’s results here and Select Medical’s results here.
There has been positive sentiment among investors in the healthcare providers & services segment, with share prices up 4.4% on average over the last month. LifeStance Health Group is up 1.7% during the same time and is heading into earnings with an average analyst price target of $9.14 (compared to the current share price of $6.62).
When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we’ve found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback.
